Inhaled colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria: A real-life experience in tertiary care hospitals in Saudi Arabia

BACKGROUND: Nosocomial pneumonia (NP) due to multidrug-resistant (MDR) Gram-negative pathogens, has continued to rise over the last several decades. Parenteral administration of colistin results in poor alveolar penetration and subtherapeutic concentration; therefore, direct drug deposition at site...

Descripción completa

Detalles Bibliográficos
Autores principales: Almangour, Thamer A., Alenazi, Basel, Ghonem, Leen, Alhifany, Abdullah A., Aldakheel, Bassam A., Alruwaili, Alya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414068/
https://www.ncbi.nlm.nih.gov/pubmed/32792845
http://dx.doi.org/10.1016/j.jsps.2020.06.023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7414068/
https://www.ncbi.nlm.nih.gov/pubmed/32792845
http://dx.doi.org/10.1016/j.jsps.2020.06.023

Ejemplares similares